Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Most patients notice some weight loss within a few weeks of starting treatment
Newsletter Signup - Under Article / In Page "*" indicates required fields Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease
The increased energy expenditure from glucagon activation means weight loss occurs partly through increased metabolic rate rather than exclusively through reduced caloric intake
Similarly, a passing reference to ileus in the Post-marketing Events section of a label (distinct from the Warnings section) does not help prescribers identify, understand, or mitigate the risk
The second option for getting the benefits of both fat and fiber is to follow a low-carb, not keto, diet
Reviewed February 2026
